CDC & FDA:  Collaboration & Challenges — FSMA, Food Outbreaks, Pharmacy 

Compounding & Emerging Health Issues

Wednesday, January 29 | Emory University | Atlanta, GA

This meeting has been cancelled due to the that fact that Emory University closed for inclement weather. 

Please email customer service if you have any questions,

General Information


Food, Diagnostics, Biologics, Drugs, Medical Devices

Course Level:

Intermediate and Advanced

Program Description

FDLI, in cooperation with Emory University, is hosting a new meeting in Atlanta. This one day symposium, featuring top FDA and CDC officials, will explain how these two critical agencies work together on a number of food and drug law issues, from outbreaks of foodborne illnesses to approval of in vitro diagnostic devices. Learn how FDA/CDC collaboration affects regulated industry—from development of guidance and regulation, to investigating product problems, to enforcement and litigation. The afternoon session provides a rare opportunity for interaction among attendees, government officials, industry representatives and public health experts.

Who Should Attend?

  • Drugs, biologics, food and medical device stakeholders regulated by FDA
  • Drugs, biologics, food and medical device stakeholders affected by CDC 
  • Compliance and regulatory specialists
  • Independent compliance and regulatory consultants
  • Government employees; regulators
  • In-house counsel
  • External attorneys
  • Students
  • Consultants
  • Academics